Among the mergers, acquisitions and finance deals our attorneys have worked on, we represented:
Novasep Holding SAS
A leading supplier of manufacturing solutions for the life science industries in the sale of its U.S. subsidiary, TangenX Technology Corporation, to Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology.
The all-cash transaction of $39 million closed on December 15, 2016.
A world-renowned leader in the provision of electronic Trial Master File (eTMF) systems and services to the life science industry in the company’s majority shareholder acquisition by Vitruvian, an independent private equity firm that specializes in middle-market investments.
The deal closed in December 2016.
Yokogawa Electric Corporation
A Japanese electrical engineering and software company with global operations in 55 countries, in its acquisition of Soteica Visual Mesa, a leading energy management technology provider.
The acquisition, announced on November 8, 2016, will enable Yokogawa to expand its cutting-edge research and innovation and advanced solution business.
Lasko Holdings, Inc.
The largest provider of portable fans and heaters in the United States in the company’s acquisition by Comvest Partners and JW Levin Management Partners (JWLMP).
The deal closed in November 2016. The financial terms of the deal were not disclosed.
A U.K.-based leading global provider of office utilization and workspace scheduling solutions, in the acquisition of myVRM, a New York-based software company with workflow automation experience in video collaboration, content sharing, unified communications, virtual meetings and analytics.
The acquisition, which was announced on June 15, 2016, will allow Condeco to offer a combined platform that simplifies video collaboration.
NeuWave Medical, Inc.
A privately held medical device company that manufactures and markets minimally invasive soft-tissue microwave ablation systems, through a major acquisition by Ethicon Endo-Surgery, Inc., a medical device company, which is part of the Johnson & Johnson family of companies. Financial terms of the transaction, which closed on April 13, 2016, have not been disclosed.
PuraCap Pharmaceutical LLC
A New Jersey-based fully integrated pharmaceutical company, and its parent company Humanwell Healthcare Group Co., Ltd. (SHA: 600079), a China-based life sciences company, in their $550 million acquisition of Epic Pharma, LLC. The acquisition will further establish Humanwell and PuraCap in the U.S. generics market and expand their existing commercial and manufacturing capabilities. The deal was announced on March 31, 2016. Under the terms of the agreement, the acquisition is subject to certain conditions, and the transaction is expected to close in the second quarter of 2016.
As New Jersey regulatory counsel in the Ireland-based online company’s recent multibillion-dollar merger with UK-based Betfair to create Paddy Power Betfair PLC, the world’s largest public online betting and gaming company. The combined companies have a gross revenue of $1.65 billion and profit before tax of $327.8 million. The deal closed on February 1, 2016.
MGM Resorts International (NYSE: MGM)
As Maryland regulatory counsel for the financing of MGM National Harbor, LLC, a new casino destination in Prince George's County, Maryland. The new $1.3 billion project will create thousands of local jobs and bolster the regional economy. The deal was announced on February 1, 2016 and is expected to be completed by the end of 2016.
RestorGenex Corporation (OTCQX:RESX)
An Illinois-based public specialty biopharmaceutical company, in its merger with Virginia-based Diffusion Pharmaceuticals, a privately held clinical stage biotechnology company. The all-stock transaction closed on January 8, 2016.
Healthcare Providers Insurance Exchange (HPIX)
A top 10 insurer of physician commercial medical professional liability in the Mid-Atlantic, in an acquisition in which HPIX’s rights, title, interests and policies were acquired by Medical Mutual Insurance Company of North Carolina, a leading provider of medical professional liability for physicians in the Southeast. The acquisition closed on January 1, 2016.
Aqua America, Inc. (NYSE: WTR)
One of the largest U.S.-based, publicly traded water utilities, in its Pennsylvania subsidiary’s acquisition of Superior Water Company, Inc. The deal closed on January 1, 2016.
M&Q Plastic Products
A family-owned company, in the sale of its operating affiliate, M&Q Packaging Corp., a manufacturer of innovative, proprietary high-temperature resistant thermoplastic nylon and polyester films, to an affiliate of Capital Partners, a private investment firm. The sale closed on December 31, 2015.
Bix Produce Company, LLC
A leader in specialty produce distribution throughout the Twin Cities metro area, greater Minnesota, Western Wisconsin, and Fargo, ND, in the sale of 100 percent of its membership interest to a private equity firm. The deal closed on December 21, 2015.
Automotive Service, Inc. (ASI)
A family-owned-and-operated fuels and lubricants distributor, in its acquisition by RelaDyne, one of the nation’s leading providers of lubricants, fuel, diesel exhaust fluid and industrial reliability services. ASI will strategically expand RelaDyne’s geographic footprint further into Eastern Pennsylvania and upstate New York, providing additional avenues for lubricant and fuel sales as well as expansion of industrial reliability solutions. The deal closed on December 17, 2015.
A premium organic food company, in its sale of Series A Preferred Stock. The financing closed on December 17, 2015.
ReliefBand Technologies LLC
A digital neurotechnology company that provides leading edge personalized medical treatment, in a $5 million Series A funding. The round was led by PathoCapital, a Chicago-based specialty health care fund. The investment will fuel the consumer market introduction of the Company’s digital, FDA-cleared, wearable device for the drug-free treatment of nausea. The financing closed on December 15, 2015. The Company’s technology was originally developed by Abbott Laboratories as part of its suite of oncology products.
A chemistry and bioconjugation company based near Philadelphia, in its acquisition by Abzena plc (AIM:ABZA), a British life sciences technology and services company, for $15 million. Under the terms of the deal, Abzena acquired TCRS for $8.8 million in cash, $1.5 million in assumed debt and the remainder in stock. The transaction closed on December 11, 2015.